Anionic pulmonary surfactant lipid regulation of innate immunity
- 1 June 2012
- journal article
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 6 (3) , 243-246
Abstract
Pulmonary surfactant is a protein- and lipid-rich complex synthesized by alveolar type 2 cells and secreted onto the air/tissue interface of the alveoli [1]. Lipids constitute approximately 90% of ...Keywords
This publication has 30 references indexed in Scilit:
- Phosphatidylglycerol Suppresses Influenza A Virus InfectionAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Pulmonary Surfactant Phosphatidylglycerol Inhibits Mycoplasma pneumoniae-stimulated Eicosanoid Production from Human and Mouse MacrophagesJournal of Biological Chemistry, 2011
- Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus–induced inflammation and infectionProceedings of the National Academy of Sciences, 2009
- Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2Journal of Biological Chemistry, 2009
- Current perspectives in pulmonary surfactant — Inhibition, enhancement and evaluationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Immunoregulatory functions of surfactant proteinsNature Reviews Immunology, 2005
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Treponemal Phospholipids Inhibit Innate Immune Responses Induced by Pathogen-associated Molecular PatternsJournal of Biological Chemistry, 2003
- Essential role of MD-2 in LPS responsiveness and TLR4 distributionNature Immunology, 2002
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000